Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Telo Genomics Corp (OP:TDSGF)

0.0340 UNCHANGED
Streaming Delayed Price Updated: 2:52 PM EST, Dec 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.0340
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0340
Today's Range 0.0340 - 0.0340
52wk Range 0.0300 - 0.1220
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Small Cap Growth Virtual Investor Conference: Presentations Now Available for Online Viewing
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Small Cap Growth Virtual Investor Conference Agenda Announced for December 9th
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire

Performance

YTD
-58.1%
-58.1%
1 Month
-28.7%
-28.7%
3 Month
-38.3%
-38.3%
6 Month
-43.5%
-43.5%
1 Year
-51.4%
-51.4%

More News

Read More
News headline image
Telo Genomics Corp to Present at the Small Cap Growth Virtual Investor Conference December 9th
From Virtual Investor Conferences; Telo Genomics Corp.
Via GlobeNewswire
News headline image
Small Cap Growth Virtual Investor Conference Agenda Announced for December 9th
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
OTCQB Venture Virtual Investor Conference: Presentations Now Available for Online Viewing
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Telo Genomics to Present at the OTCQB Venture Virtual Investor Conference
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
OTCQB Venture Virtual Investor Conference Agenda Announced for August 7th
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
EXCLUSIVE: Telo Genomics' Smoldering Multiple Myeloma Prognostic Test Predicts Risk Of Disease Progression, Study Shows ↗
Via Benzinga
News headline image
Telo Genomics Completes International Standards Organization ("ISO") 15189 Final Accreditation
Via Newsfile
News headline image
Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030
Via FinancialNewsMedia
News headline image
Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030
Via FinancialNewsMedia
News headline image
Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030
From FN Media Group LLC
Via GlobeNewswire
Telo Genomics Announces Clinical Launch of Non-Invasive Cancer Diagnostic, TeloViewSMM – An Important Commercial Milestone Achieved
Via FinancialNewsMedia
Topics Artificial Intelligence
Telo Genomics Presents Positive Results in Assessing MRD in Multiple Myeloma Patients at the International Myeloma Society Annual Meeting
Via FinancialNewsMedia
News headline image
Telo Genomics Announces Achieving Interim Results from Smouldering Myeloma Clinical Study
Via Newsfile

Frequently Asked Questions

Is Telo Genomics Corp publicly traded?
Yes, Telo Genomics Corp is publicly traded.
What exchange does Telo Genomics Corp trade on?
Telo Genomics Corp trades on the OTC Traded
What is the ticker symbol for Telo Genomics Corp?
The ticker symbol for Telo Genomics Corp is TDSGF on the OTC Traded
What is the current price of Telo Genomics Corp?
The current price of Telo Genomics Corp is 0.0340
When was Telo Genomics Corp last traded?
The last trade of Telo Genomics Corp was at 12/09/25 02:52 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.